PCSK9 and atherosclerosis: In the results, the top 10 compounds with binding energies from -9.8 to -8.2 kcal/mol (S2 Table), are comparable to the reference compounds (S1 Table) and hence are favorable and valid potential drug candidates for targeting PCSK9 in atherosclerosis.